Product division
Pharma Intermediates & Building Blocks
Advanced and key starting materials, heterocycles, chiral building blocks and reagents for API synthesis, from gram R&D to multi-tonne supply.
9,200products
4sub-categories
1,292in stock
COA + SDSwith every lot
Organic Building Blocks 5,617Heterocyclic Building Blocks 1,587Bulk Pharma Intermediates 22API Process Intermediates & Related Compounds 1,974
(3-(((2S,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid
- CAS
- 172822-01-4
- Formula
- C23H22F7N4O6P
- MW
- 614.41 g/mol
VQ-048465
(3-Bromo-2,4,6-trimethylphenylcarbamoyl)methyliminodiacetic acid, 98%+
- CAS
- 78266-06-5
- Formula
- C15H19BrN2O5
- MW
- 387.23 g/mol
VQ-008188
(3-Chlorophenyl)(phenyl)methanamine Hydrochloride
- CAS
- 5267-37-8
- Formula
- C13H13Cl2N
- MW
- 254.15 g/mol
VQ-009176
(3-Ethoxy-4-methoxyphenyl)boronic acid, extra pure
- CAS
- 915201-13-7
- Formula
- C9H13BO4
- MW
- 196.01 g/mol
VQ-020106
(3aR,12bR)-rel-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
- CAS
- 912356-08-2
- Formula
- C17H14ClNO2
- MW
- 299.7 g/mol
In stock
(3AR,4S,7R,7aS)-3a,4,7,7a-Tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
- CAS
- 1356221-52-7
- Formula
- C9H9NO2
- MW
- 163.17 g/mol
VQ-038209
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
- CAS
- 1062580-52-2
- Formula
- C14H24Cl2N2
- MW
- 291.3 g/mol
VQ-012755
(3R,4S)-3-[(Triethylsilyl)oxy]-4-phenyl-2-azetidinone
- CAS
- 149140-54-5
- Formula
- C15H23NO2Si
- MW
- 277.43 g/mol
VQ-048054
(3R)-3-(7-Amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
- CAS
- 874946-00-6
- Formula
- C13H13N3O3
- MW
- 259.26 g/mol
VQ-044079
(3R)-3-Aminoazepane-1-carboxylic Acid tert-Butyl Ester
- CAS
- 1032684-85-7
- Formula
- C11H22N2O2
- MW
- 214.3 g/mol
In stock
Need a price, a spec or a custom compound?
Send us your list — product names or CAS numbers, grade, quantity and destination. Our team replies with a formal quotation, COA and lead time.